BioCentury | Dec 2, 2020
Distillery Therapeutics

Blocking PCSK9 alone or with anti-PD-1 therapies for cancer

...evaluate anti-PCSK9 therapies in combination with checkpoint inhibitors in patients.Amgen Inc. (NASDAQ:AMGN), Astellas Pharma Inc. (Tokyo:4503) and Dr. Reddy's Laboratories...
BioCentury | Nov 25, 2020
Product Development

Russia to launch Sputnik V vaccine into global orbit

...V, and plants in China and India have also started manufacturing the vaccine, said Dmitriev. Steve Usdin Dr. Reddy's Laboratories...
BioCentury | Nov 5, 2020
Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

...region and succeeds Jean-Michel Boers, who is now president and CEO of Boehringer Ingelheim USA Corp. Dr. Reddy's Laboratories...
...Therapeutics Inc. (NASDAQ:MRTX), Aspen Neuroscience Inc. and Gossamer Bio Inc. (NASDAQ:GOSS). Danielle Golovin Boehringer Ingelheim Horizon Therapeutics plc GlaxoSmithKline plc Dr. Reddy's Laboratories...
BioCentury | Sep 5, 2020
Product Development

Sept. 4 Quick Takes: HiFiBiO in second cancer deal with Gilead; plus Bridgewest-Pfizer, Amarin, Intercept, Santhera-Idorsia, CMS, Ascendis

...AMR-101, LAX-101) Ocaliva, obeticholic acid (DSP-1747, 6ecdca, int-747, oca) Vamorolone (VBP15) Gilead Sciences Inc. Kite Pharma Inc. HiFiBiO Therapeutics Amarin Corp. plc Dr. Reddy's Laboratories...
BioCentury | Jul 3, 2020
Deals

July 2 Quick Takes: Novartis to ante up $678M in settlement; plus Zai, Neoleukin, Base Genomics, Sarepta-Hansa, Dr. Reddy-Fujifilm

...mild to moderate COVID-19. BioCentury Staff IdeS, imlifidase Avigan, favipiravir (T-705) Hansa Biopharma AB Sarepta Therapeutics Inc. Zai Lab Ltd. Fujifilm Holdings Corp. Dr. Reddy's Laboratories...
BioCentury | Mar 31, 2020
Product Development

Amarin set to appeal patent ruling that points way to generic competition for Vascepa

...tied to COVID-19. Paul Bonanos, Associate Editor Vascepa (amr101, icosapent ethyl, miraxion, AMR-101, LAX-101) Amarin Corp. plc Hikma Pharmaceuticals plc Dr. Reddy's Laboratories...
BioCentury | Sep 26, 2019
Politics & Policy

MNCs gain ground in China’s centralized procurement

...Co. Ltd. Merck & Co. Inc. Eli Lilly and Co. Sanofi Chia Tai Tianqing Pharmaceutical Group Co. Ltd. Novartis AG Pfizer Inc. Dr. Reddy's Laboratories...
BioCentury | Jul 26, 2019
Finance

Earnings on deck

...exchanges; (B) Fiscal 1Q Company Date Pre/post mkt 2Q19 EPS est 2Q18 EPS Expected chg Dr. Reddy's Laboratories...
BioCentury | Jul 3, 2019
Emerging Company Profile

Kymera: a systematic approach to protein degradation

...have clinical compounds targeting IRAK4 for oncology and autoimmune indications, according to BioCentury's BCIQ database. Dr. Reddy's Laboratories...
...C4 Therapeutics Inc., Watertown, Mass. Cedilla Therapeutics Inc., Cambridge, Mass. Cullgen Inc., San Diego, Calif. Dr. Reddy's Laboratories...
...myeloid differentiation primary respose gene 88 Inhua Muijrers-Chen, Associate Editor Arvinas Inc. C4 Therapeutics Inc. Cedilla Therapeutics Inc. Cullgen Inc. Dr. Reddy's Laboratories...
BioCentury | May 11, 2019
Finance

Earnings on deck

...1.41 -10% Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) (A) 5/14 Post ¥131.09 (B) ¥192.83 (B) NA Dr. Reddy's Laboratories...
Items per page:
1 - 10 of 206
BioCentury | Dec 2, 2020
Distillery Therapeutics

Blocking PCSK9 alone or with anti-PD-1 therapies for cancer

...evaluate anti-PCSK9 therapies in combination with checkpoint inhibitors in patients.Amgen Inc. (NASDAQ:AMGN), Astellas Pharma Inc. (Tokyo:4503) and Dr. Reddy's Laboratories...
BioCentury | Nov 25, 2020
Product Development

Russia to launch Sputnik V vaccine into global orbit

...V, and plants in China and India have also started manufacturing the vaccine, said Dmitriev. Steve Usdin Dr. Reddy's Laboratories...
BioCentury | Nov 5, 2020
Management Tracks

Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more

...region and succeeds Jean-Michel Boers, who is now president and CEO of Boehringer Ingelheim USA Corp. Dr. Reddy's Laboratories...
...Therapeutics Inc. (NASDAQ:MRTX), Aspen Neuroscience Inc. and Gossamer Bio Inc. (NASDAQ:GOSS). Danielle Golovin Boehringer Ingelheim Horizon Therapeutics plc GlaxoSmithKline plc Dr. Reddy's Laboratories...
BioCentury | Sep 5, 2020
Product Development

Sept. 4 Quick Takes: HiFiBiO in second cancer deal with Gilead; plus Bridgewest-Pfizer, Amarin, Intercept, Santhera-Idorsia, CMS, Ascendis

...AMR-101, LAX-101) Ocaliva, obeticholic acid (DSP-1747, 6ecdca, int-747, oca) Vamorolone (VBP15) Gilead Sciences Inc. Kite Pharma Inc. HiFiBiO Therapeutics Amarin Corp. plc Dr. Reddy's Laboratories...
BioCentury | Jul 3, 2020
Deals

July 2 Quick Takes: Novartis to ante up $678M in settlement; plus Zai, Neoleukin, Base Genomics, Sarepta-Hansa, Dr. Reddy-Fujifilm

...mild to moderate COVID-19. BioCentury Staff IdeS, imlifidase Avigan, favipiravir (T-705) Hansa Biopharma AB Sarepta Therapeutics Inc. Zai Lab Ltd. Fujifilm Holdings Corp. Dr. Reddy's Laboratories...
BioCentury | Mar 31, 2020
Product Development

Amarin set to appeal patent ruling that points way to generic competition for Vascepa

...tied to COVID-19. Paul Bonanos, Associate Editor Vascepa (amr101, icosapent ethyl, miraxion, AMR-101, LAX-101) Amarin Corp. plc Hikma Pharmaceuticals plc Dr. Reddy's Laboratories...
BioCentury | Sep 26, 2019
Politics & Policy

MNCs gain ground in China’s centralized procurement

...Co. Ltd. Merck & Co. Inc. Eli Lilly and Co. Sanofi Chia Tai Tianqing Pharmaceutical Group Co. Ltd. Novartis AG Pfizer Inc. Dr. Reddy's Laboratories...
BioCentury | Jul 26, 2019
Finance

Earnings on deck

...exchanges; (B) Fiscal 1Q Company Date Pre/post mkt 2Q19 EPS est 2Q18 EPS Expected chg Dr. Reddy's Laboratories...
BioCentury | Jul 3, 2019
Emerging Company Profile

Kymera: a systematic approach to protein degradation

...have clinical compounds targeting IRAK4 for oncology and autoimmune indications, according to BioCentury's BCIQ database. Dr. Reddy's Laboratories...
...C4 Therapeutics Inc., Watertown, Mass. Cedilla Therapeutics Inc., Cambridge, Mass. Cullgen Inc., San Diego, Calif. Dr. Reddy's Laboratories...
...myeloid differentiation primary respose gene 88 Inhua Muijrers-Chen, Associate Editor Arvinas Inc. C4 Therapeutics Inc. Cedilla Therapeutics Inc. Cullgen Inc. Dr. Reddy's Laboratories...
BioCentury | May 11, 2019
Finance

Earnings on deck

...1.41 -10% Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) (A) 5/14 Post ¥131.09 (B) ¥192.83 (B) NA Dr. Reddy's Laboratories...
Items per page:
1 - 10 of 206